BRPI0511846A - utilização de lipopolissacarìdeo em condensado de respiração exalado para diagnosticar pneumonia gram-negativa - Google Patents

utilização de lipopolissacarìdeo em condensado de respiração exalado para diagnosticar pneumonia gram-negativa

Info

Publication number
BRPI0511846A
BRPI0511846A BRPI0511846-8A BRPI0511846A BRPI0511846A BR PI0511846 A BRPI0511846 A BR PI0511846A BR PI0511846 A BRPI0511846 A BR PI0511846A BR PI0511846 A BRPI0511846 A BR PI0511846A
Authority
BR
Brazil
Prior art keywords
lipopolysaccharide
exhaled breath
breathing
gram
breath condensate
Prior art date
Application number
BRPI0511846-8A
Other languages
English (en)
Inventor
Jeffrey A Kline
Jackeline Hernandez
John Albert Watts Jr
Original Assignee
Charlotte Mecklenburg Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charlotte Mecklenburg Hospital filed Critical Charlotte Mecklenburg Hospital
Publication of BRPI0511846A publication Critical patent/BRPI0511846A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/0813—Measurement of pulmonary parameters by tracers, e.g. radioactive tracers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/097—Devices for facilitating collection of breath or for directing breath into or through measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412—Detecting or monitoring sepsis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)

Abstract

UTILIZAçãO DE LIPOPOLISSACARìDEO EM CONDENSADO DE RESPIRAçãO EXALADO PARA DIAGNOSTICAR PNEUMONIA GRAM-NEGATIVA. A presente invenção refere-se a um método para determinar se um indivíduo possui uma pneumonia bacteriana Gram-negativa com base na presença de lipopolissacarídeo em condensado de respiração exalado coletado a partir de um individuo. Os dispositivos de coleta utilizado para coletar condensado de respiração exalado tanto a partir de indivíduos que respiram espontaneamente ou mecanicamente ventilados e os dispositivos utilizados para determinar se o lipopolissacarídeo está presente no condensado de respiração exalado.
BRPI0511846-8A 2004-06-07 2005-05-24 utilização de lipopolissacarìdeo em condensado de respiração exalado para diagnosticar pneumonia gram-negativa BRPI0511846A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57764104P 2004-06-07 2004-06-07
PCT/US2005/018232 WO2006007180A2 (en) 2004-06-07 2005-05-24 Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia

Publications (1)

Publication Number Publication Date
BRPI0511846A true BRPI0511846A (pt) 2008-01-15

Family

ID=35784291

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511846-8A BRPI0511846A (pt) 2004-06-07 2005-05-24 utilização de lipopolissacarìdeo em condensado de respiração exalado para diagnosticar pneumonia gram-negativa

Country Status (8)

Country Link
EP (1) EP1761166A4 (pt)
JP (2) JP4804464B2 (pt)
AU (1) AU2005262701B2 (pt)
BR (1) BRPI0511846A (pt)
CA (1) CA2566804A1 (pt)
IL (5) IL179137A (pt)
MX (1) MXPA06014248A (pt)
WO (1) WO2006007180A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7547285B2 (en) 2003-02-14 2009-06-16 The Charlotte-Mecklenburg Hospital Authority Device and method for collection of exhaled alveolar breath condensate
BR0316872B1 (pt) 2002-12-20 2014-02-18 Aparelho coletor de condensação de respiração.
US7828741B2 (en) 2002-12-20 2010-11-09 The Charlotte-Mecklenburg Hospital Authority Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
AU2008307788A1 (en) * 2007-10-02 2009-04-09 Almstrand, Anne-Charlotte Collection and measurement of exhaled particles
CN102057275A (zh) * 2008-06-04 2011-05-11 凯希特许有限公司 检测减压伤口治疗中的感染
GB201312635D0 (en) * 2013-07-15 2013-08-28 Univ Plymouth Water testing
US10413216B2 (en) * 2016-02-03 2019-09-17 Quintron Instrument Company, Inc. Breath testing apparatus
CN106018362B (zh) * 2016-05-16 2018-06-08 江苏国恒检测有限公司 一种检测苦味酸的测定器
CN108871908B (zh) * 2018-09-06 2024-06-25 杭州优思达生物技术股份有限公司 生物样本处理装置
EP4021294A4 (en) 2019-08-26 2023-07-12 Zeteo Tech, Inc. DIAGNOSIS OF TUBERCULOSIS AND OTHER DISEASES BY EXHALATED AIR
WO2023038582A2 (en) * 2021-09-10 2023-03-16 National University Of Singapore Exhaled breath condensate collection kit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59383A (en) * 1980-02-14 1983-03-31 Technion Res & Dev Foundation Micromethod for the determination of endotoxins with limulus amebocyte lysate
US4349626A (en) * 1980-10-28 1982-09-14 The Monell Chemical Senses Center Method of detecting Pseudomonas aeruginosa infections utilizing selected ketone and/or sulfur metabolites
US5541057A (en) * 1989-09-18 1996-07-30 Biostar, Inc. Methods for detection of an analyte
SE9704329D0 (sv) * 1997-11-25 1997-11-25 Siemens Elema Ab Gasmätare
JP2002541429A (ja) * 1998-12-18 2002-12-03 ユニバーシティ オブ バージニア パテント ファウンデーション 喘息を監視するための装置と方法
WO2000054050A2 (en) * 1999-03-09 2000-09-14 Osmetech Plc Method for detecting conditions by analysis of aqueous condensate from respiratory gases
AU2001261091A1 (en) * 2000-05-01 2001-11-12 Respiratory Research, Inc. Method and device for collecting and analyzing exhaled breath
US20040234971A1 (en) * 2001-02-01 2004-11-25 Joany Jackman Diagnosis of pathogen infections using mass spectral analysis of immune system modulators in post-exposure biological samples

Also Published As

Publication number Publication date
JP4804464B2 (ja) 2011-11-02
CA2566804A1 (en) 2006-01-19
IL218191A0 (en) 2012-04-30
AU2005262701A1 (en) 2006-01-19
WO2006007180A2 (en) 2006-01-19
JP2009186487A (ja) 2009-08-20
WO2006007180A3 (en) 2006-11-30
IL218190A0 (en) 2012-04-30
JP2008501976A (ja) 2008-01-24
MXPA06014248A (es) 2007-06-25
AU2005262701B2 (en) 2011-12-01
IL179137A (en) 2012-07-31
EP1761166A4 (en) 2009-11-11
IL179137A0 (en) 2007-03-08
IL218189A0 (en) 2012-04-30
EP1761166A2 (en) 2007-03-14
IL218188A0 (en) 2012-04-30
JP4852121B2 (ja) 2012-01-11

Similar Documents

Publication Publication Date Title
BRPI0511846A (pt) utilização de lipopolissacarìdeo em condensado de respiração exalado para diagnosticar pneumonia gram-negativa
CA2605959A1 (en) USE OF LIPOPOLYSACCHARIDE IN EXHALE BREATH CONDENSATE FOR THE DIAGNOSIS OF GRAM NEGATIVE GERMINAL PNEUMONIA
Zellweger et al. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB)
Hui et al. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission
Zhang et al. Monitoring SARS-CoV-2 in air and on surfaces and estimating infection risk in buildings and buses on a university campus
Ramsey et al. Use of bacterial antigen detection in the diagnosis of pediatric lower respiratory tract infections
Subali et al. The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.
WO2006003029A3 (en) Detection of tuberculosis and infection by mycobacterium tuberculosis using hbha
Van Kerkhove et al. Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015
Hollanders et al. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the serological diagnosis of sarcoptic mange in swine
Bresalier ‘A Most Protean Disease’: Aligning Medical Knowledge of Modern Influenza, 1890–1914
LeResche et al. Epidemiology of chronic pain
Díaz et al. Short-term effects of pollen species on hospital admissions in the city of Madrid in terms of specific causes and age
Liu et al. Health risk analysis of indoor air pollution
Flodin et al. Non-sensitising air pollution at workplaces and adult onset asthma
Corwin et al. Impact of epidemic influenza A-like acute respiratory illness in a remote jungle highland population in Irian Jaya, Indonesia
Bartolini et al. Immunochromatographic assays for COVID-19 epidemiological screening: our experience
Gubina et al. Prevalenca protiteles proti bakteriji Helicobacter pylori v Sloveniji v letu 2005
Simonsen et al. Characterization of the extent of a large outbreak of Legionnaires’ disease by serological assays
Nkunzimana et al. Clinical and epidemiology characteristics of COVID-19 cases detected during mass screening Campaign from July to October 2020 in Bujumbura, Burundi
Park et al. Community-based epidemiologic study on atherosclerotic cardiovascular risk factors
IYENGAR et al. Resuming elective surgery during the COVID-19 pandemic
Sorensen The importance of monitoring carbon monoxide levels in indoor ice skating rinks
Nice et al. Exploring spatial planning and functional program impact on microbial diversity and distribution in two South African hospital microbiomes
BRPI0617500B8 (pt) kit de imunoensaio para a detecção de veneno de loxosceles reclusa

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2309 DE 07/04/2015.